Explore a selection of peer-reviewed publications highlighting the scientific achievements and collaborative research efforts of CD3 and its partners.
News & Insights
News
CD3 announces investment in Enedra Therapeutics to advance drug discovery programmes from its proprietary CASPAROV platform for difficult to treat cancers
CD3 announces investment in Enedra Therapeutics to advance drug discovery programmes from its proprietary CASPAROV platform for difficult to treat cancers
Read More
KU Leuven joins EndLyz Therapeutics’ fight against Parkinson’s disease
KU Leuven joins EndLyz Therapeutics’ fight against Parkinson’s disease
Read More
Assembly of coronavirus particles as a new target for the development of potent antiviral drugs
Assembly of coronavirus particles as a new target for the development of potent antiviral drugs
Read More Success Stories
Pioneering TRPM3 Inhibitors for Non‑Opioid Pain Relief
Pioneering TRPM3 Inhibitors for Non‑Opioid Pain Relief
Read More
From Hippo mutant flies to YAP/TEAD inhibitors for hard-to-treat cancers
From Hippo mutant flies to YAP/TEAD inhibitors for hard-to-treat cancers
Read More
From Academic Insight to Phase II: Birth of a First in Class Dengue Antiviral Programme